ARG1 and neoplasm: Furthermore, our data showed that CN133 in combination with anti-PD-1 improved efficacy significantly which was achieved in the subcutaneous murine PCa models by decreasing tumor-infiltrating PMN-MDSCs and their expression of functional molecules Arg-1 and iNOS.